Literature DB >> 2409221

Interactions of monovalent cations with sodium channels in squid axon. II. Modification of pharmacological inactivation gating.

J Z Yeh, G S Oxford.   

Abstract

The time-, frequency-, and voltage-dependent blocking actions of several cationic drug molecules on open Na channels were investigated in voltage-clamped, internally perfused squid giant axons. The relative potencies and time courses of block by the agents (pancuronium [PC], octylguanidinium [C8G], QX-314, and 9-aminoacridine [9-AA]) were compared in different intracellular ionic solutions; specifically, the influences of internal Cs, tetramethylammonium (TMA), and Na ions on block were examined. TMA+ was found to inhibit the steady state block of open Na channels by all of the compounds. The time-dependent, inactivation-like decay of Na currents in pronase-treated axons perfused with either PC, 9-AA, or C8G was retarded by internal TMA+. The apparent dissociation constants (at zero voltage) for interaction between PC and 9-AA with their binding sites were increased when TMA+ was substituted for Cs+ in the internal solution. The steepness of the voltage dependence of 9-AA or PC block found with internal Cs+ solutions was greatly reduced by TMA+, resulting in estimates for the fractional electrical distance of the 9-AA binding site of 0.56 and 0.22 in Cs+ and TMA+, respectively. This change may reflect a shift from predominantly 9-AA block in the presence of Cs+ to predominantly TMA+ block. The depth, but not the rate, of frequency-dependent block by QX-314 and 9-AA is reduced by internal TMA+. In addition, recovery from frequency-dependent block is not altered. Elevation of internal Na produces effects on 9-AA block qualitatively similar to those seen with TMA+. The results are consistent with a scheme in which the open channel blocking drugs, TMA (and Na) ions, and the inactivation gate all compete for a site or for access to a site in the channel from the intracellular surface. In addition, TMA ions decrease the apparent blocking rates of other drugs in a manner analogous to their inhibition of the inactivation process. Multiple occupancy of Na channels and mutual exclusion of drug molecules may play a role in the complex gating behaviors seen under these conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409221      PMCID: PMC2215806          DOI: 10.1085/jgp.85.4.603

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  21 in total

1.  Arginine-specific reagents remove sodium channel inactivation.

Authors:  D C Eaton; M S Brodwick; G S Oxford; B Rudy
Journal:  Nature       Date:  1978-02-02       Impact factor: 49.962

2.  Immobilisation of gating charge by a substance that simulates inactivation.

Authors:  J Z Yeh; C M Armstrong
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

3.  Inactivation of the sodium channel. II. Gating current experiments.

Authors:  C M Armstrong; F Bezanilla
Journal:  J Gen Physiol       Date:  1977-11       Impact factor: 4.086

4.  The effect of changing the internal solution on sodium inactivation and related phenomena in giant axons.

Authors:  W K Chandler; A L Hodgkin; H Meves
Journal:  J Physiol       Date:  1965-10       Impact factor: 5.182

5.  Removal of sodium channel inactivation in squid giant axons by n-bromoacetamide.

Authors:  G S Oxford; C H Wu; T Narahashi
Journal:  J Gen Physiol       Date:  1978-03       Impact factor: 4.086

6.  Destruction of the sodium conductance inactivation by a specific protease in perfused nerve fibres from Loligo.

Authors:  E Rojas; B Rudy
Journal:  J Physiol       Date:  1976-11       Impact factor: 5.182

7.  Kinetic analysis of pancuronium interaction with sodium channels in squid axon membranes.

Authors:  J Z Yeh; T Narahashi
Journal:  J Gen Physiol       Date:  1977-03       Impact factor: 4.086

8.  Magnitude and location of surface charges on Myxicola giant axons.

Authors:  T Begenisich
Journal:  J Gen Physiol       Date:  1975-07       Impact factor: 4.086

9.  Selective modification of sodium channel gating in lobster axons by 2, 4, 6-trinitrophenol: Evidence for two inactivation mechanisms.

Authors:  G S Oxford; J P Pooler
Journal:  J Gen Physiol       Date:  1975-12       Impact factor: 4.086

10.  The permeability of the sodium channel to organic cations in myelinated nerve.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1971-12       Impact factor: 4.086

View more
  7 in total

1.  Block of sodium channels by internal mono- and divalent guanidinium analogues. Modulation by sodium ion concentration.

Authors:  M Danko; C Smith-Maxwell; L McKinney; T Begenisich
Journal:  Biophys J       Date:  1986-02       Impact factor: 4.033

2.  A quantitative description of QX222 blockade of sodium channels in squid axons.

Authors:  C F Starmer; J Z Yeh; J Tanguy
Journal:  Biophys J       Date:  1986-04       Impact factor: 4.033

3.  Tail currents in the myelinated axon of Xenopus laevis suggest a two-open-state Na channel.

Authors:  F Elinder; P Arhem
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

4.  Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.

Authors:  Y Qu; J Rogers; T Tanada; T Scheuer; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Inactivation of calcium current in bull-frog atrial myocytes.

Authors:  D L Campbell; W R Giles; J R Hume; E F Shibata
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

6.  Interactions of monovalent cations with sodium channels in squid axon. I. Modification of physiological inactivation gating.

Authors:  G S Oxford; J Z Yeh
Journal:  J Gen Physiol       Date:  1985-04       Impact factor: 4.086

7.  Inhibition of sodium currents by local anesthetics in chloramine-T-treated squid axons. The role of channel activation.

Authors:  G K Wang; M S Brodwick; D C Eaton; G R Strichartz
Journal:  J Gen Physiol       Date:  1987-04       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.